3322632

Information

• Patent Grant
• 3322632

• References
• Source

• Patent Number

  3,322,632

• Date Filed

  Not available

• Date Issued

  Tuesday, May 30, 1967
  57 years ago

• CPC

  • C12N7/00 - Viruses Bacteriophages Compositions thereof Preparation or purification thereof
  • A01N25/22 - containing ingredients stabilising the active ingredients
  • A61K39/0233 - Rickettsiales
  • A61K39/04 - Mycobacterium
  • A61K39/05 - Actinobacteria
  • A61K39/08 - Clostridium
  • A61K39/099 - Bordetella
  • A61K39/12 - Viral antigens
  • A61K39/13 - Poliovirus
  • A61K39/17 - Newcastle disease virus
  • A61K39/39591 - Stabilisation, fragmentation
  • C12N1/04 - Preserving or maintaining viable micro-organisms
  • C12N9/96 - Stabilising an enzyme by forming an adduct or a composition Forming enzyme conjugates
  • A61K2039/5252 - inactivated (killed)
  • A61K2039/55505 - Inorganic adjuvants
  • A61K2039/70 - Multivalent vaccine
  • C12N2760/18134 - Use of virus or viral component as vaccine
  • C12N2770/32634 - Use of virus or viral component as vaccine
  • C12N2770/32651 - Methods of production or purification of viral material
  • Y10S436/826 - Additives

• US Classifications

  • 435 - Chemistry: molecular biology and microbiology
  • 424 - Drug, bio-affecting and body treating compositions
  • 436 - Chemistry: analytical and immunological testing
  • 514 - Drug, bio-affecting and body treating compositions